Ericsson Trieu
Physician Assistant · Whittier, CANPI 1144685504
Payments from drug & device makers
Across 264 payments — averaging $22.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$713
- Amgen$704
- Radius Health, Inc.$482
- Johnson & Johnson$477
- UCB, Inc.$458
- Lilly USA, LLC$374
- plus $3K from 23 others
What the payments were for
- Consulting fees$1753%
- Food & beverage$5,85197%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $713 |
| Amgen(2 entities) | 30 | $704 |
| Radius Health, Inc. | 18 | $482 |
| Johnson & Johnson | 21 | $477 |
| UCB, Inc. | 21 | $458 |
| Lilly USA, LLC | 15 | $374 |
| AstraZeneca(2 entities) | 18 | $374 |
| Novartis | 15 | $348 |
| Boehringer Ingelheim | 15 | $342 |
| Aurinia Pharma U.S., Inc. | 13 | $314 |
| Fresenius Kabi USA, LLC | 8 | $257 |
| Pfizer | 11 | $248 |
| Sanofi | 4 | $107 |
| Alvogen Inc | 5 | $105 |
| Sandoz | 4 | $101 |
| Actelion Pharmaceuticals US, Inc. | 4 | $91 |
| Organon | 5 | $89 |
| GSK | 3 | $73 |
| Cumberland Pharmaceuticals, Inc. | 2 | $68 |
| Mallinckrodt Hospital Products Inc. | 2 | $53 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $51 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $45 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Genentech USA, Inc. | 3 | $29 |
| Kyowa Kirin, Inc. | 1 | $26 |
| Celltrion USA Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $21 |
| Sobi, Inc | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$175
How this compares
$6,048 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 134 | $1,015,366 |
| RinvoqUpadacitinib | 106 | $673,302 |
| Enbrel SureclickEtanercept | 64 | $557,839 |
| ProliaDenosumab | 295 | $490,888 |
| TremfyaGuselkumab | 25 | $326,930 |
| Orencia ClickjectAbatacept | 39 | $260,524 |
| Xeljanz XrTofacitinib Citrate | 42 | $247,613 |
| TymlosAbaloparatide | 58 | $189,291 |
| EnbrelEtanercept | 23 | $164,790 |
| Humira PenAdalimumab | 17 | $154,744 |
| Taltz AutoinjectorIxekizumab | 16 | $152,373 |
| Cimzia (2 Pack)Certolizumab Pegol | 25 | $149,751 |
| Teriparatide | 46 | $136,387 |
| Enbrel MiniEtanercept | 14 | $101,570 |
| OfevNintedanib Esylate | 12 | $94,183 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia, Enbrel, Evenity (2 Syringes) | $704 | $727,193348 claims |
| AbbVieRinvoq, Savella | $713 | $681,716124 claims |
| Johnson & JohnsonTremfya, Remicade | $477 | $378,87438 claims |
| Radius Health, Inc.Tymlos | $482 | $189,29158 claims |
| UCB, Inc.Cimzia (2 Pack) | $458 | $149,75125 claims |
| Alvogen IncTeriparatide | $105 | $136,38746 claims |
| Boehringer IngelheimOfev | $342 | $94,18312 claims |
| Lilly USA, LLCForteo | $374 | $74,90216 claims |
| SanofiKevzara | $107 | $55,48813 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $38 | $7,13040 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Whittier
- Erin BoriniWhittier$59K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.